Medlab Clinical Share Price Up on Agreement with Pharmascience


At time of writing the share price of Medlab Clinical Limited [ ASX:MDC ] is up 9.86%, trading at 39 cents. It has been a rocky year for the stock with the recent announcement a welcome reprieve for long-term investors:     Source: The latest news out of the company is that it has announced a Heads of Agreement with Canadian pharmaceutical company Pharmascience Inc. Thinking of adding a pot stock to your portfolio?

Ga naar Bron